Adjustment of the area under the concentration curve by terminal rate constant for bioequivalence assessment in a parallel‐group study of lamotrigine

摘要

A new strength of lamotrigine extended‐release formulation unexpectedly failed to show bioequivalence with the existing strengths at the same dose in a parallel‐group study. We report the analyses conducted to identify the cause and propose an approach for future evaluations in similar situations.